Private Advisory Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-3,713
Closed -$340K – 332
2026
Q2
$340K Buy
3,713
+120
+3% +$10.5K 0.02% 249
2026
Q1
$306K Sell
3,593
-3,422
-49% -$305K 0.02% 241
2025
Q4
$554K Buy
7,015
+3,622
+107% +$284K 0.04% 155
2025
Q3
$271K Buy
3,393
+268
+9% +$22.9K 0.02% 193
2025
Q2
$284K Buy
+3,125
New +$285K 0.03% 181

Other funds holding CL

Private Advisory Group's CL Position: Q3 2026 in Review

Private Advisory Group sold out of Colgate-Palmolive (CL) in Q3 2026, closing a stake of 3,713 shares — an estimated $340K sold.

Private Advisory Group first reported a position in CL in Q2 2025 and held it in 5 quarters. The position peaked at $554K in Q4 2025. 1,565 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Private Advisory Group reported no remaining Colgate-Palmolive position as of Q3 2026 after selling out during the quarter.
  • Private Advisory Group sold 3,713 Colgate-Palmolive shares in Q3 2026, an estimated $340K.
  • Private Advisory Group first reported a position in Colgate-Palmolive in Q2 2025 and held it in 5 quarters.
  • Private Advisory Group's Colgate-Palmolive position peaked at $554K in Q4 2025.
  • 1,565 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Private Advisory Group's 13F filing for Q3 2026, filed 6 Nov 2026.